Enzo Biochem, Inc. (NYSE:ENZ)
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Up on huge volume.
Recs
What do you think, is this company good manged ?
When I read other pitch it seem not. But I think earning money is not the goal.
They are building knowledge for future...
The stock is cheap, potential high and when other pharmaceutic company will have cash again...
Recs
Recs
They're makin' money.
Recs
The company will be sold within several months
Recs
Okay, Enzo took their hit and lost $5 in one day. At $12.56, they are a good value stock in a good bio-tech player, looking to rebound. If they win the litigation, they will pop up over $18.. maybe $20.
Let's get real. They have over 200 patents and 180 more pending. This is THEM suing others for infringment.. it is not like THEY were the ones infringing. I find it hard to believe 25-30% of their value was solely based upon this suit and it's outcome.
I think if you were a previous "inderperform" voter, now would be a good time to see that this stock has corrected and is due to head upward from here, at tleast doe the next 1-2 years.
I see this stock hitting $15-16 in the next 3-6 months. You can wait and watch or pan the stock and miss out on the upward movement.
I'm in for 500 shares at $12.58.
Recs
Oversold
Recs
US District Court ruled against this bio-chemical company in a patent infringement case brought by this company. The six disputed patents relate to the company's method and materials for detecting nucleic acid sequences. Lost $5
Recs
Will win patent ligigation with Applera
Recs
ENZO OWNS OVER 200 BIO TECH PATENTS. MANY
PRODUCTS IN SECOND STAGE. A HORDE OF CASH .CHECK THEIR WEBSITE. TALK TO LARZARD WHO DID A SUBSTANTIAL PLACEMENT LAST YEAR. THE SHOT INTEREST AS OF 12 JUN- 18.3% , INSTITUTIONS HOLD 41%. YOU CAN ALSO CALL ED LEWIS AT CEOcast 212-732-4300
Recs
stock price moved upwards in spite of negative consensus. In stock market peple who vote with their money (buying power)ften overweight people vote with their heart. A company no one loves usually does better in the long run.
Recs
12/18/06 from Red Herring-- Life sciences firm Enzo Biochem, which launched a patent war by claiming that it invented a technique central to DNA sequencing, has raised $43.1 million by selling stock to institutional investors.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 12 of 12